HSV-1 amplicon-mediated post-transcriptional inhibition of Rad51 sensitizes human glioma cells to ionizing radiation
- 10 May 2007
- journal article
- Published by Springer Nature in Gene Therapy
- Vol. 14 (15) , 1143-1151
- https://doi.org/10.1038/sj.gt.3302967
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Inhibition of homologous recombination repair in irradiated tumor cells pretreated with Hsp90 inhibitor 17-allylamino-17-demethoxygeldanamycinBiochemical and Biophysical Research Communications, 2006
- Mechanisms of eukaryotic DNA double strand break repairFrontiers in Bioscience-Landmark, 2006
- Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategyNature, 2005
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaNew England Journal of Medicine, 2005
- siRNAs: applications in functional genomics and potential as therapeuticsNature Reviews Drug Discovery, 2004
- siRNA-based inhibition specific for mutant SOD1 with single nucleotide alternation in familial ALS, compared with ribozyme and DNA enzymeBiochemical and Biophysical Research Communications, 2004
- Helper Virus-Free Herpes Simplex Virus Type 1 Amplicon Vectors for Granulocyte-Macrophage Colony-Stimulating Factor-Enhanced Vaccination Therapy for Experimental GliomaHuman Gene Therapy, 2000
- In Vitroandin VivoPotentiation of Radiosensitivity of Malignant Gliomas by Antisense Inhibition of the RAD51 GeneBiochemical and Biophysical Research Communications, 1998
- Regulation of Rad51 Function by c-Abl in Response to DNA DamageJournal of Biological Chemistry, 1998
- Antisense Inhibition of the RAD51 Enhances RadiosensitivityBiochemical and Biophysical Research Communications, 1996